Cargando…

Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Screening for latent tuberculosis infection (LTBI) is mandatory before commencing tumor necrosis factor (TNF)-α inhibitor use. However, the impact of immunosuppressive therapy (IST), including corticosteroids and immunomodulators, on the performance of LTBI screening in patients with inflammatory bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Chan Hyuk, Park, Jung Ho, Jung, Yoon Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953543/ https://www.ncbi.nlm.nih.gov/pubmed/35330505 http://dx.doi.org/10.3390/jpm12030507

Ejemplares similares

Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression—risks, screening, diagnosis and management
por: Fehily, Sasha R., et al.
Publicado: (2022)

Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease
por: Nguyen, Huyen-Tran, et al.
Publicado: (2017)

Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: A systematic review and meta‐analysis
por: Jung, Yoon Suk, et al.
Publicado: (2023)

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment
por: Yoopetch, Panida, et al.
Publicado: (2022)

Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease
por: Alrajhi, Saad, et al.
Publicado: (2020)

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU
por: Riestra, Sabino, et al.
Publicado: (2022)

Systematic review of nutrition screening and assessment in inflammatory bowel disease
por: Li, Suqing, et al.
Publicado: (2019)

The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review
por: Greenaway, Christina, et al.
Publicado: (2018)

Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis
por: Wang, Xiaobing, et al.
Publicado: (2019)

Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy
por: Çekiç, Cem, et al.
Publicado: (2015)

Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease
por: Boicean, Adrian, et al.
Publicado: (2023)

Impact of temperature and humidity on performance of the fecal immunochemical test for advanced colorectal neoplasia
por: Park, Chan Hyuk, et al.
Publicado: (2019)

Comparison of Interferon-Gamma Release Assay and Tuberculin Skin Test for the Screening of Latent Tuberculosis in Inflammatory Bowel Disease Patients: Indian Scenario
por: Mantri, Alok Kumar, et al.
Publicado: (2021)

It's Time for Latent Tuberculosis Infection Screening in HIV-infected Individuals
por: Park, Chan Kwon, et al.
Publicado: (2019)

Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines
por: Hasan, Tasnim, et al.
Publicado: (2018)

Screening and Treatment of Latent Tuberculosis Infection among Healthcare Workers at a Referral Hospital in Korea
por: Park, Se Yoon, et al.
Publicado: (2019)

Comparison of Risk of Metachronous Advanced Colorectal Neoplasia in Patients with Sporadic Adenomas Aged < 50 Versus ≥ 50 years: A Systematic Review and Meta-Analysis
por: Jung, Yoon Suk, et al.
Publicado: (2021)

755. Clinical Adherence to Latent Tuberculosis Screening Recommendations in Adults with Inflammatory Bowel Disease (IBD) Prior to Biologic Therapy
por: Mponponsuo, Kwadwo, et al.
Publicado: (2018)

Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
por: Kim, Min Chul, et al.
Publicado: (2016)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

Comparison of Diagnostic Performance of Ultrasonography and Magnetic Resonance Enterography in the Assessment of Active Bowel Lesions in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis
por: Lee, Da In, et al.
Publicado: (2022)

The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease—A Systematic Literature Review
por: Wiersma, Thomas K., et al.
Publicado: (2022)

Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease
por: Kang, Jieun, et al.
Publicado: (2018)

Urolithiasis in inflammatory bowel disease and bariatric surgery
por: Gkentzis, Agapios, et al.
Publicado: (2016)

Fatigue in children and adolescents with inflammatory bowel disease
por: Van de Vijver, Els, et al.
Publicado: (2019)

Insufficient Knowledge of Korean Gastroenterologists Regarding the Vaccination of Patients with Inflammatory Bowel Disease
por: Jung, Yoon Suk, et al.
Publicado: (2014)

Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea
por: Jung, Yoon Suk
Publicado: (2020)

Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis
por: Park, Youngmok, et al.
Publicado: (2018)

Comparative Efficacy of Tegoprazan vs Esomeprazole/Sodium Bicarbonate for the Treatment of Helicobacter pylori Infection
por: Park, Chan Hyuk, et al.
Publicado: (2023)

Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Zupo, Roberta, et al.
Publicado: (2022)

Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results
por: Jung, Yoon Suk, et al.
Publicado: (2018)

Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases
por: Pyo, Junhee, et al.
Publicado: (2018)

Management of inflammatory bowel disease with Clostridium difficile infection
por: D’Aoust, Julie, et al.
Publicado: (2017)

Systematic review—pancreatic involvement in inflammatory bowel disease
por: Massironi, Sara, et al.
Publicado: (2022)

Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials
por: Assefa, Dawit Getachew, et al.
Publicado: (2023)

Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases
por: Ballou, Sarah, et al.
Publicado: (2017)

Efficacy of Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-Analysis
por: Gong, Eun Jeong, et al.
Publicado: (2022)

QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment
por: Lee, Hyun, et al.
Publicado: (2015)

Efficacy of Eltrombopag with Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone on Severe Aplastic Anaemia: A Systematic Review and Meta-analysis
por: Zhang, Senlin, et al.
Publicado: (2023)

Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
por: Hahn, Gustavo Drügg, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vlbp39g6ss1sigfme7n9dsnf4d